Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut.
Int J Eat Disord. 2020 Jan;53(1):20-30. doi: 10.1002/eat.23167. Epub 2019 Sep 9.
This study examined whether sex predicted and/or moderated treatment outcomes among men and women who participated in binge-eating disorder (BED) randomized controlled trials (RCTs).
Data were aggregated from RCTs performed at one medical center. RCTs tested cognitive-behavioral therapy, behavioral weight loss, multimodal treatment, and/or control conditions. Participants were 660 adults, both men (n = 170) and women (n = 490), with Diagnostic and Statistical Manual-fourth edition (DSM-IV)-defined BED. Doctoral-level research-clinicians assessed participants using structured interviews and established self-report measures of eating-disorder psychopathology and depression, and measured height and weight. Assessments occurred at baseline, throughout treatment, and at post-treatment.
Sex was not a significant moderator of any treatment outcomes. Mixed models revealed sex had a main effect: men had lower eating-disorder psychopathology and lost more weight than women over the course of treatment.
Both epidemiological and RCT studies report disparities in treatment-seeking between men and women with BED. Despite this, men have comparable or better treatment outcomes compared with women, including significantly greater weight loss. Thus, disseminating evidence-based BED treatments is promising for both men and women. Additional research is necessary, however, to understand treatment effects-including other predictors and moderators of outcomes-across diverse providers, treatment settings, and patient groups.
本研究考察了性别是否预测和/或调节了参加暴食障碍(BED)随机对照试验(RCT)的男性和女性的治疗结果。
数据来自一个医学中心进行的 RCT 汇总。RCT 测试了认知行为疗法、行为减肥、多模式治疗和/或对照条件。参与者为 660 名成年人,包括男性(n=170)和女性(n=490),均符合 DSM-IV 定义的 BED。博士级别的研究临床医生使用结构化访谈和已建立的饮食障碍病理学和抑郁的自我报告评估工具对参与者进行评估,并测量身高和体重。评估在基线时、治疗期间和治疗后进行。
性别不是任何治疗结果的显著调节因素。混合模型显示性别有主要影响:男性在治疗过程中比女性的饮食障碍病理学程度更低,体重减轻更多。
流行病学和 RCT 研究都报告了 BED 患者寻求治疗的性别差异。尽管如此,男性与女性相比,治疗结果相当或更好,包括体重明显减轻更多。因此,为男性和女性传播基于证据的 BED 治疗方法是有希望的。然而,需要进一步研究,以了解在不同的提供者、治疗环境和患者群体中,治疗效果的其他预测因素和调节因素。